Skip to main content
logo
NATCO Pharma Limited (BOM:524816)
India flag India · Delayed Price · Currency is INR
1,016.75
-158.85 (-13.51%)
At close: May 29, 2026

NATCO Pharma Revenue

In the fiscal year ending March 31, 2026, NATCO Pharma had annual revenue of 43.76B INR, down -1.26%. NATCO Pharma had revenue of 8.17B in the quarter ending March 31, 2026, a decrease of -33.23%.

Revenue
43.76B
Revenue Growth
-1.26%
P/S Ratio
4.16
Revenue / Employee
10.42M
Employees
4,199
Market Cap
181.96B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202643.76B-560.00M-1.26%
Mar 31, 202544.32B4.30B10.74%
Mar 31, 202440.02B12.94B47.76%
Mar 31, 202327.09B7.62B39.17%
Mar 31, 202219.46B-1.10B-5.35%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jubilant Pharmova82.80B
Granules India53.66B
J. B. Chemicals & Pharmaceuticals41.48B
GlaxoSmithKline Pharmaceuticals38.22B
Viyash Scientific34.20B
AstraZeneca Pharma India22.76B
Caplin Point Laboratories21.87B
Sanofi India17.74B
Revenue Rankings

NATCO Pharma News

More News